Towards new AQP4 inhibitors: ORI-TRN-002
M. Thormann, N. Traube, N. Yehia, R. Kostler, G. Galabova, N. MacAulay, T. L. Toft-Bertelsen
This paper identifies ORI-TRN-002 as a novel AQP4 inhibitor with improved solubility and low protein binding, potentially useful for antiedema therapy.
bioRxiv · Nov 22, 2023Pharmacology & Toxicology